Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

231
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
231
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

346
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
346
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

349
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
349
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

347
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
347

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Myeloid Sarcoma Arising From a Mediastinal Mass Encasing the Aorta: Diagnostic Pitfalls and Challenges.

JACC. Case reports·2026
Same author

The 2026 Multisociety Acute Pulmonary Embolism Guidelines: An Expert Perspective.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Systolic doming or 'hockey-stick sign' of the aortic valve in rheumatic valve disease.

Journal of visualized surgery·2026
Same author

Machine Learning in Postcardiotomy Shock: Implications for Temporary Mechanical Circulatory Support.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

To Intervene or Not to Intervene: Rethinking Non-culprit Vessels in Acute Coronary Syndrome.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Artificial intelligence-enhanced electrocardiogram findings before and after heart transplantation in cardiac amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026

Related Experiment Video

Updated: Jan 6, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K

Early Postoperative Aortic Root Thrombus After Heartmate 3.

Jama Jahanyar1, Joshua M Liao, Patrick DeValeria

  • 1Department of Cardiothoracic Surgery, Mayo Clinic Hospital, Scottsdale/Phoenix, AZ. jjahanyar@gmail.com.

The Heart Surgery Forum
|October 10, 2019
PubMed
Summary

Heartmate 3 (HM3) left ventricular assist device implantation is a viable option for advanced heart failure. A rare aortic root thrombus complication was observed following HM3 implantation after Impella 5.0 support.

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Related Experiment Videos

Last Updated: Jan 6, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.7K
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.1K

Area of Science:

  • Cardiology
  • Medical Devices
  • Surgical Procedures

Background:

  • The Heartmate 3 (HM3) left ventricular assist device (LVAD) is a key therapy for end-stage congestive heart failure, serving as a bridge to heart transplantation.
  • The HM3 has demonstrated favorable outcomes in clinical trials, such as the Momentum 3 trial, when compared to its predecessor, the Heartmate 2.
  • Left ventricular assist devices are increasingly used in managing advanced heart failure, offering improved survival and quality of life.

Observation:

  • This report details the first documented case of an aortic root thrombus developing early after HM3 implantation.
  • The patient received an Impella 5.0 device prior to the HM3 implantation as part of their treatment strategy.
  • The thrombus formation occurred in the aortic root, a critical component of the left ventricular outflow tract.

Findings:

  • The occurrence of aortic root thrombus in this case was noted early in the post-HM3 implantation period.
  • A potential link is suggested between the preceding Impella 5.0 support and the subsequent thrombus formation.
  • The proposed mechanism involves potential aortic valve and aortic root injury from the Impella 5.0, leading to stasis after HM3 support.

Implications:

  • This case highlights a potential, albeit rare, complication associated with a specific sequence of mechanical circulatory support devices.
  • Clinicians should be aware of the possibility of aortic root thrombus in patients who have undergone Impella 5.0 support followed by HM3 implantation.
  • Further investigation may be warranted to elucidate the precise mechanisms and risk factors for this complication, informing future patient management strategies.